Daymark’s first-of-its kind, tech-enabled cancer platform provides personalized support by addressing clinical, social and mental health needs of patients, caregivers

PROVIDENCE, R.I. — Blue Cross & Blue Shield of Rhode Island (BCBSRI) has teamed up with Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, to offer Daymark’s evidence-based supportive care to over 2,500 BCBSRI members undergoing cancer treatment.

BCBSRI members undergoing cancer treatment now have the opportunity to be supported by Daymark’s tech-enabled care platform and team of community-based clinicians to better meet their clinical, social, and mental health needs — both virtually and in the home. BCBSRI is working with Rhode Island-based providers to collaboratively transform cancer care, by wrapping Daymark’s first-of-its-kind program around the existing clinical care workflows. This unique collaboration is designed in close partnership with Rhode Island cancer institutes to achieve timely access to care, improved outcomes, and a supportive experience of care for members undergoing cancer treatment. 

“There is nothing scarier than being diagnosed with cancer and feeling alone navigating the healthcare system,” said Martha L. Wofford, President and CEO of BCBSRI. “Now with Daymark, our members consistently tell us that they feel supported, and that care feels more coordinated, more personal, and less overwhelming. We are so pleased to be teaming up with Daymark to deliver this exceptional patient experience and to support access to outstanding care and advanced treatments. Importantly, we are doing this in collaboration with our local provider partners, to better serve our members with cancer.”

Daymark Health is a cancer care company that works with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Daymark's supportive, personalized cancer care program empowers patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home. 

Daymark is supported by a $20 million Series A funding round led by Healthier Capital with Blue Venture Fund, with participation from existing investors including Maverick Ventures, Yosemite, and Oncology Ventures.

“We are seeing a tipping point in oncology, where payers feel the ongoing pressures of managing specialty risk—helping members access timely care and delivering an exceptional experience—and providers are seeking solutions that put patients first,” said Dr. Justin Bekelman, oncologist and CEO and Co-Founder of Daymark Health. “We built Daymark Health to provide compassionate, intelligent, and frictionless cancer care at scale and are honored to collaborate closely with BCBSRI and our new investors to advance cancer care across the U.S.”

Healthier Capital partners with technology-powered innovators to deliver healthier outcomes for all, and was founded by Amir Dan Rubin, former CEO of One Medical, the tech-enabled primary care organization which is now part of Amazon. Blue Venture Fund is a unique collaboration among Blue Cross and Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, to which 36 BCBS companies and special purpose licensees have committed over $1.2 billion across five funds. The investment from these organizations underscores the industry-wide recognition that oncology is entering a period of rapid change, with payers and providers aligned on the need for more integrated, sustainable models of care. The company will add Healthier Capital’s Dr. Aman Mahajan and Blue Venture Fund’s Kelsey Maguire to its board. 

“Daymark is breaking down the silos in healthcare delivery to better enable personalized care for patients with cancer, while improving outcomes and reducing avoidable costs,” said Aman Mahajan, MD, PhD, Partner at Healthier Capital. “Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care.”

“Daymark and Blue Venture Fund are passionate about a shared purpose: to give all patients the best possible care experience, driving better health outcomes and ensuring they feel seen, heard, and valued,” said Kelsey Maguire, Managing Director at the Blue Venture Fund. “We’re thrilled to partner with Daymark as they redefine the cancer care experience and evolve what’s possible in value-based oncology.”